AGIO
Agios Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -7.7% ·
Aktienfluss -1.1% ·
neue Nettopositionen -8.3%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +3 | 38.62M | $1.43B | +11 | −8 |
| Q1 2026 | 89 | 0 | 33.63M | $1.14B | +5 | −5 |
| Q4 2025 | 89 | -2 | 38.17M | $1.04B | — | −2 |
| Q3 2025 | 19 | +2 | 22.49M | $902.53M | +2 | −1 |
| Q2 2025 | 15 | 0 | 21.02M | $699.20M | — | — |
| Q1 2025 | 12 | -1 | 9.99M | $292.81M | — | −1 |
| Q4 2024 | 13 | +2 | 10.10M | $332.03M | +2 | — |
| Q3 2024 | 10 | 0 | 7.27M | $323.20M | — | — |
| Q2 2024 | 10 | — | 7.12M | $306.93M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 2.45M | +13.8% | $71.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.30M | -5.0% | $67.43M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 2.30M | -5.0% | $67.43M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 1.39M | +3.3% | $40.87M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.39M | +3.3% | $40.87M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 959.34K | -0.1% | $28.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 863.50K | -39.8% | $25.30M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 863.50K | -39.8% | $25.30M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 743.00K | +145.2% | $21.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 554.82K | +7.4% | $16.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 554.82K | +7.4% | $16.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Marshall Wace ✦ | 520.87K | -17.5% | $15.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Norges Bank ✦ (passiv) | 77.54K | -46.6% | $2.27M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Millennium Management ✦ | 53.07K | +139.1% | $1.56M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 51.49K | +66.8% | $1.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 51.49K | +66.8% | $1.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 51.49K | +66.8% | $1.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 51.49K | +66.8% | $1.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 51.49K | +66.8% | $1.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Wellington Management ✦ | 24.46K | -4.0% | $716,738 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Wellington Management ✦ | 24.46K | -4.0% | $716,738 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Wellington Management ✦ | 24.46K | -4.0% | $716,738 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Wellington Management ✦ | 24.46K | -4.0% | $716,738 | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Two Sigma Investments | $3.59M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 231 Inhaber, 62.89M Anteile, $1.99B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.